US11718612B2

Inhibitors of receptor interacting protein kinase I for the treatment of …

University of Texas System

Abstract

Disclosed herein are compounds which inhibit RIPK1, pharmaceutical compositions, and methods of treatment of RIPK1-mediated diseases, such as neurodegenerative disorders, inflammatory disorders, and cancer.

University: University of Texas System
Assignee: Board Of Regents, The University Of Texas System
Inventor: Richard T. Lewis
Priority date: September 06, 2019
Filing date: September 08, 2020
Grant date: August 08, 2023
Publication date: August 08, 2023
Language: en
PDF source: https://patentimages.storage.googleapis.com/7b/e4/47/f9b756763762b6/US11718612.pdf
Metadata fetched: August 29, 2026 00:30